世界のマイクロバイオーム治療市場規模・現状・予測2021-2027

【英語タイトル】Global Microbiome Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR3760)・商品コード:QY21APR3760
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:130
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥998,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、マイクロバイオーム治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アッパーGIT、ローワーGIT)、用途別市場規模(炎症性腸疾患(IBD)、希少疾病用医薬品、免疫腫瘍、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・マイクロバイオーム治療の市場動向
・企業の競争状況、市場シェア
・マイクロバイオーム治療の種類別市場規模(アッパーGIT、ローワーGIT)
・マイクロバイオーム治療の用途別市場規模(炎症性腸疾患(IBD)、希少疾病用医薬品、免疫腫瘍、その他)
・マイクロバイオーム治療の北米市場規模2016-2027(アメリカ、カナダ)
・マイクロバイオーム治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・マイクロバイオーム治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・マイクロバイオーム治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・マイクロバイオーム治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Seres Therapeutics、Assembly Biosciences、Synthetic Biologics、Interxon、PureTech、Synlogic、Enterome BioScience、4D Pharma、Second Genome、AOBiome、C3 Jian、Rebiotix、MicroBiome Therapeutics LLC、Metabiomics、Ritter Pharmaceuticals、Symberix、OpenBiome、Azitra、Symbiotix Biotherapies、Osel、Metabogen)
・結論
【レポートの概要】

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that’s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.

Market Analysis and Insights: Global Microbiome Therapeutics Market
The global Microbiome Therapeutics market size is projected to reach US$ 553.9 million by 2026, from US$ 41 million in 2019, at a CAGR of 44.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microbiome Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microbiome Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microbiome Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microbiome Therapeutics market.

Global Microbiome Therapeutics Scope and Market Size
Microbiome Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Upper GIT
Lower GIT

Segment by Application
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
Interxon
PureTech
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market by Application
1.3.1 Global Microbiome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-Oncology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Microbiome Therapeutics Market Perspective (2016-2027)
2.2 Microbiome Therapeutics Growth Trends by Regions
2.2.1 Microbiome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Therapeutics Industry Dynamic
2.3.1 Microbiome Therapeutics Market Trends
2.3.2 Microbiome Therapeutics Market Drivers
2.3.3 Microbiome Therapeutics Market Challenges
2.3.4 Microbiome Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue
3.4 Global Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2020
3.5 Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapeutics Breakdown Data by Type
4.1 Global Microbiome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2022-2027)

5 Microbiome Therapeutics Breakdown Data by Application
5.1 Global Microbiome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Microbiome Therapeutics Market Size (2016-2027)
6.2 North America Microbiome Therapeutics Market Size by Type
6.2.1 North America Microbiome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Microbiome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Microbiome Therapeutics Market Size by Type (2016-2027)
6.3 North America Microbiome Therapeutics Market Size by Application
6.3.1 North America Microbiome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Microbiome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Microbiome Therapeutics Market Size by Application (2016-2027)
6.4 North America Microbiome Therapeutics Market Size by Country
6.4.1 North America Microbiome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Microbiome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Microbiome Therapeutics Market Size (2016-2027)
7.2 Europe Microbiome Therapeutics Market Size by Type
7.2.1 Europe Microbiome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Microbiome Therapeutics Market Size by Application
7.3.1 Europe Microbiome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Microbiome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Microbiome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Microbiome Therapeutics Market Size by Country
7.4.1 Europe Microbiome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Microbiome Therapeutics Market Size (2016-2027)
9.2 Latin America Microbiome Therapeutics Market Size by Type
9.2.1 Latin America Microbiome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Microbiome Therapeutics Market Size by Application
9.3.1 Latin America Microbiome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Microbiome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Microbiome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Microbiome Therapeutics Market Size by Country
9.4.1 Latin America Microbiome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Details
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2016-2021)
11.1.5 Seres Therapeutics Recent Development
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Details
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2016-2021)
11.2.5 Assembly Biosciences Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2016-2021)
11.3.5 Synthetic Biologics Recent Development
11.4 Interxon
11.4.1 Interxon Company Details
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Therapeutics Introduction
11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2016-2021)
11.4.5 Interxon Recent Development
11.5 PureTech
11.5.1 PureTech Company Details
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Therapeutics Introduction
11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2016-2021)
11.5.5 PureTech Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Therapeutics Introduction
11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2016-2021)
11.6.5 Synlogic Recent Development
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Details
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Therapeutics Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2016-2021)
11.7.5 Enterome BioScience Recent Development
11.8 4D Pharma
11.8.1 4D Pharma Company Details
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Therapeutics Introduction
11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2016-2021)
11.8.5 4D Pharma Recent Development
11.9 Second Genome
11.9.1 Second Genome Company Details
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Therapeutics Introduction
11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2016-2021)
11.9.5 Second Genome Recent Development
11.10 AOBiome
11.10.1 AOBiome Company Details
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Therapeutics Introduction
11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2016-2021)
11.10.5 AOBiome Recent Development
11.11 C3 Jian
11.11.1 C3 Jian Company Details
11.11.2 C3 Jian Business Overview
11.11.3 C3 Jian Microbiome Therapeutics Introduction
11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2016-2021)
11.11.5 C3 Jian Recent Development
11.12 Rebiotix
11.12.1 Rebiotix Company Details
11.12.2 Rebiotix Business Overview
11.12.3 Rebiotix Microbiome Therapeutics Introduction
11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2016-2021)
11.12.5 Rebiotix Recent Development
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Details
11.13.2 MicroBiome Therapeutics LLC Business Overview
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction
11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2016-2021)
11.13.5 MicroBiome Therapeutics LLC Recent Development
11.14 Metabiomics
11.14.1 Metabiomics Company Details
11.14.2 Metabiomics Business Overview
11.14.3 Metabiomics Microbiome Therapeutics Introduction
11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2016-2021)
11.14.5 Metabiomics Recent Development
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Details
11.15.2 Ritter Pharmaceuticals Business Overview
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction
11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2016-2021)
11.15.5 Ritter Pharmaceuticals Recent Development
11.16 Symberix
11.16.1 Symberix Company Details
11.16.2 Symberix Business Overview
11.16.3 Symberix Microbiome Therapeutics Introduction
11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2016-2021)
11.16.5 Symberix Recent Development
11.17 OpenBiome
11.17.1 OpenBiome Company Details
11.17.2 OpenBiome Business Overview
11.17.3 OpenBiome Microbiome Therapeutics Introduction
11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2016-2021)
11.17.5 OpenBiome Recent Development
11.18 Azitra
11.18.1 Azitra Company Details
11.18.2 Azitra Business Overview
11.18.3 Azitra Microbiome Therapeutics Introduction
11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2016-2021)
11.18.5 Azitra Recent Development
11.18 Symbiotix Biotherapies
.1 Symbiotix Biotherapies Company Details
.2 Symbiotix Biotherapies Business Overview
.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction
.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2016-2021)
.5 Symbiotix Biotherapies Recent Development
11.20 Osel
11.20.1 Osel Company Details
11.20.2 Osel Business Overview
11.20.3 Osel Microbiome Therapeutics Introduction
11.20.4 Osel Revenue in Microbiome Therapeutics Business (2016-2021)
11.20.5 Osel Recent Development
11.21 Metabogen
11.21.1 Metabogen Company Details
11.21.2 Metabogen Business Overview
11.21.3 Metabogen Microbiome Therapeutics Introduction
11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2016-2021)
11.21.5 Metabogen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 4. Global Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Microbiome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Microbiome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Microbiome Therapeutics Market Share by Regions (2022-2027)
Table 10. Microbiome Therapeutics Market Trends
Table 11. Microbiome Therapeutics Market Drivers
Table 12. Microbiome Therapeutics Market Challenges
Table 13. Microbiome Therapeutics Market Restraints
Table 14. Global Microbiome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Microbiome Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapeutics as of 2020)
Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Microbiome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Microbiome Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Microbiome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Microbiome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Microbiome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Seres Therapeutics Company Details
Table 62. Seres Therapeutics Business Overview
Table 63. Seres Therapeutics Microbiome Therapeutics Product
Table 64. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Seres Therapeutics Recent Development
Table 66. Assembly Biosciences Company Details
Table 67. Assembly Biosciences Business Overview
Table 68. Assembly Biosciences Microbiome Therapeutics Product
Table 69. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Assembly Biosciences Recent Development
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Microbiome Therapeutics Product
Table 74. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Synthetic Biologics Recent Development
Table 76. Interxon Company Details
Table 77. Interxon Business Overview
Table 78. Interxon Microbiome Therapeutics Product
Table 79. Interxon Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Interxon Recent Development
Table 81. PureTech Company Details
Table 82. PureTech Business Overview
Table 83. PureTech Microbiome Therapeutics Product
Table 84. PureTech Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 85. PureTech Recent Development
Table 86. Synlogic Company Details
Table 87. Synlogic Business Overview
Table 88. Synlogic Microbiome Therapeutics Product
Table 89. Synlogic Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Synlogic Recent Development
Table 91. Enterome BioScience Company Details
Table 92. Enterome BioScience Business Overview
Table 93. Enterome BioScience Microbiome Therapeutics Product
Table 94. Enterome BioScience Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Enterome BioScience Recent Development
Table 96. 4D Pharma Company Details
Table 97. 4D Pharma Business Overview
Table 98. 4D Pharma Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 99. 4D Pharma Recent Development
Table 100. Second Genome Company Details
Table 101. Second Genome Business Overview
Table 102. Second Genome Microbiome Therapeutics Product
Table 103. Second Genome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Second Genome Recent Development
Table 105. AOBiome Company Details
Table 106. AOBiome Business Overview
Table 107. AOBiome Microbiome Therapeutics Product
Table 108. AOBiome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 109. AOBiome Recent Development
Table 110. C3 Jian Company Details
Table 111. C3 Jian Business Overview
Table 112. C3 Jian Microbiome Therapeutics Product
Table 113. C3 Jian Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 114. C3 Jian Recent Development
Table 115. Rebiotix Company Details
Table 116. Rebiotix Business Overview
Table 117. Rebiotix Microbiome Therapeutics Product
Table 118. Rebiotix Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Rebiotix Recent Development
Table 120. MicroBiome Therapeutics LLC Company Details
Table 121. MicroBiome Therapeutics LLC Business Overview
Table 122. MicroBiome Therapeutics LLC Microbiome Therapeutics Product
Table 123. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 124. MicroBiome Therapeutics LLC Recent Development
Table 125. Metabiomics Company Details
Table 126. Metabiomics Business Overview
Table 127. Metabiomics Microbiome Therapeutics Product
Table 128. Metabiomics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Metabiomics Recent Development
Table 130. Ritter Pharmaceuticals Company Details
Table 131. Ritter Pharmaceuticals Business Overview
Table 132. Ritter Pharmaceuticals Microbiome Therapeutics Product
Table 133. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Ritter Pharmaceuticals Recent Development
Table 135. Symberix Company Details
Table 136. Symberix Business Overview
Table 137. Symberix Microbiome Therapeutics Product
Table 138. Symberix Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Symberix Recent Development
Table 140. OpenBiome Company Details
Table 141. OpenBiome Business Overview
Table 142. OpenBiome Microbiome Therapeutics Product
Table 143. OpenBiome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 144. OpenBiome Recent Development
Table 145. Azitra Company Details
Table 146. Azitra Business Overview
Table 147. Azitra Microbiome Therapeutics Product
Table 148. Azitra Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 149. Azitra Recent Development
Table 150. Symbiotix Biotherapies Company Details
Table 151. Symbiotix Biotherapies Business Overview
Table 152. Symbiotix Biotherapies Microbiome Therapeutics Product
Table 153. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 154. Symbiotix Biotherapies Recent Development
Table 155. Osel Company Details
Table 156. Osel Business Overview
Table 157. Osel Microbiome Therapeutics Product
Table 158. Osel Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 159. Osel Recent Development
Table 160. Metabogen Company Details
Table 161. Metabogen Business Overview
Table 162. Metabogen Microbiome Therapeutics Product
Table 163. Metabogen Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 164. Metabogen Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Upper GIT Features
Figure 3. Lower GIT Features
Figure 4. Global Microbiome Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Inflammatory Bowel Disease (IBD) Case Studies
Figure 6. Orphan Drug Case Studies
Figure 7. Immuno-Oncology Case Studies
Figure 8. Others Case Studies
Figure 9. Microbiome Therapeutics Report Years Considered
Figure 10. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Microbiome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Microbiome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Microbiome Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Microbiome Therapeutics Market Share by Players in 2020
Figure 15. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2020
Figure 17. Global Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Microbiome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Microbiome Therapeutics Market Share by Region (2016-2027)
Figure 39. China Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 59. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 60. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 61. Interxon Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 62. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 63. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 64. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 65. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 66. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 67. AOBiome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 68. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 69. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 70. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 71. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 72. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 73. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 74. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 75. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 76. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 77. Osel Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 78. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed


【掲載企業】

Seres Therapeutics、Assembly Biosciences、Synthetic Biologics、Interxon、PureTech、Synlogic、Enterome BioScience、4D Pharma、Second Genome、AOBiome、C3 Jian、Rebiotix、MicroBiome Therapeutics LLC、Metabiomics、Ritter Pharmaceuticals、Symberix、OpenBiome、Azitra、Symbiotix Biotherapies、Osel、Metabogen

★調査レポート[世界のマイクロバイオーム治療市場規模・現状・予測2021-2027] (コード:QY21APR3760)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のマイクロバイオーム治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆